SCHEDULE 13G

Company

Silo Pharma, Inc.

Filed

July 26, 2024

Accession Number

0001013762-24-001611

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →